GeoVax stockholders approve reverse stock split and warrant share issuance at special meeting

GeoVax Labs, Inc.

Reverse split authorized at ratio between 1:10 and 1:25, with 11.85M votes for and 2.16M against.
Issuance of up to 11,904,768 shares upon exercise of September 2025 warrants approved (5.81M for, 0.95M against).
Record date September 30, 2025; 29.71M shares outstanding; 14.13M proxies cast.
Board retains discretion to determine final split ratio and timing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.